1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Iress Limited
  6. News
  7. Summary
    IRE   AU000000IRE2

IRESS LIMITED

(IRE)
  Report
Delayed Quote. Delayed Australian Stock Exchange - 05/18 10:53:36 pm
10.37 AUD   -1.89%
05/04TRANSCRIPT : Iress Limited - Shareholder/Analyst Call
CI
04/25IRESS : Five ways client engagement can boost your business
PU
04/20IRESS : Update - Notification of buy-back - IRE
PU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Iress : The life-changing value of top-quality protection advice

12/17/2021 | 05:09am EDT
This case study from Vitality shows an example of comprehensive severity-based cover in action and why it is more likely to pay out in the event of a claim. Choosing the right cover

Nine years ago, protection adviser Alan Knowles, managing director of Cura, was approached by his client, Melanie* and her partner. They were looking to review their protection in light of a new mortgage. After considering all options, Alan recommended they take a Vitality Life and Serious Illness Cover (SIC) plan.

"They were very keen on quality not price," he explains. "We, therefore, went for comprehensive cover [Serious Illness Cover Plus] rather than primary cover [Serious Illness Cover]. For £350,000 worth of cover, having the full amount for Serious Illness Cover was considered too expensive for the client - so we opted for £90,000 SIC for each partner [with the rest as Life Cover]. We included her two children on the plan too, before adding their third child a year or two later."

A diagnosis

Alan kept in touch with Melanie over the proceeding years, reviewing their cover periodically. Nothing changed significantly until an interaction earlier this year revealed they were remortgaging. Her partner had received an alternative quote from elsewhere, so this triggered another review by Cura.

During the process, she revealed that a year or so ago she had been diagnosed with rheumatoid arthritis; a long-term condition that causes pain, swelling and stiffness in the joints, usually the hands, feet and wrists.

On hearing about the diagnosis, Alan immediately thought of two things. "Firstly, this could impact a new policy [if that was something they wanted]. Secondly, a claim might be possible because her condition might be covered by her existing plan."

The claim

Alan asked Melanie if she'd informed Vitality about the diagnosis to see if a claim was possible. "She just said, 'No, because it doesn't really affect me that much. I've never had any time off work because of it. It hasn't really got in the way of me doing anything.'"

To manage her expectations, Alan told her he would contact Vitality to find out whether her condition met the definition. "At that time, even though I knew Rheumatoid Arthritis was covered, I wasn't sure exactly to what extent. I thought there might be certain requirements such as a specific level of symptoms or medication of some kind."

"I was able to tell my client she could make an unexpected claim worth almost £10k. Based on diagnosis alone, she would not have got a pay-out anywhere else" Alan Knowles, MD, Cura

On further investigation, Alan realised that Rheumatoid Arthritis was covered for diagnosis alone under the plan as a low severity payment (10%). After speaking to his account manager at Vitality, he was able to go back to his client and confirm she was able to receive a pay-out of £9,000 (10%) with the rest of her cover remaining in place.

Unique condition

Melanie's situation is a real-life example of a Serious Illness Cover claim that would not be covered by any other provider, under critical illness plans. It would also not have qualified for an Income Protection pay-out either, because she has not needed any time off work.

Hitting home the life-changing value of top-quality protection advice, Melanie's experience is an example of comprehensive severity-based cover in action and how it is more likely to pay out.

None of us can predict the future - so why leave your clients' future health situation to chance?

Why Serious Illness Cover?

Find out more about the unique benefits on offer for your clients.

A version of this article originally appeared on Vitality Insights Hub

*Name has been changed

Disclaimer

IRESS Limited published this content on 17 December 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 17 December 2021 10:08:12 UTC.


ę Publicnow 2021
All news about IRESS LIMITED
05/04TRANSCRIPT : Iress Limited - Shareholder/Analyst Call
CI
04/25IRESS : Five ways client engagement can boost your business
PU
04/20IRESS : Update - Notification of buy-back - IRE
PU
04/19Australian shares rise on tech and healthcare boost; Ramsay soars on $14.8 bln bid
RE
04/18IRESS : Update - Notification of buy-back - IRE
PU
04/12Australian Shares Fall on Prospects of More Aggressive US Fed Rate Hikes
MT
04/12IRESS : Successfully transitioning to an operating model underpinned by technology
PU
04/11Iress Nixes Planned Divestment of UK Mortgage Business
MT
04/10IRESS : Update - Notification of buy-back - IRE
PU
04/07IRESS : Making sense of ESG investment options
PU
More news
Financials
Sales 2022 629 M 440 M 440 M
Net income 2022 65,9 M 46,1 M 46,1 M
Net Debt 2022 273 M 191 M 191 M
P/E ratio 2022 30,4x
Yield 2022 4,41%
Capitalization 1 970 M 1 377 M 1 377 M
EV / Sales 2022 3,56x
EV / Sales 2023 3,34x
Nbr of Employees 2 224
Free-Float 91,7%
Chart IRESS LIMITED
Duration : Period :
Iress Limited Technical Analysis Chart | IRE | AU000000IRE2 | MarketScreener
Technical analysis trends IRESS LIMITED
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 7
Last Close Price 10,57 AUD
Average target price 12,22 AUD
Spread / Average Target 15,6%
EPS Revisions
Managers and Directors
Andrew Leslie Walsh Chief Executive Officer, MD & Executive Director
John Harris Chief Financial Officer
Roger Sharp Chairman
Andrew Todd Chief Technology Officer
John Alexander Duncan Cameron Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
IRESS LIMITED-15.20%1 386
INTUIT INC.-42.19%105 169
FIDELITY NATIONAL INFORMATION SERVICES, INC.-9.94%60 035
ADYEN N.V.-36.45%47 919
WORLDLINE-24.10%10 994
KAKAO PAY CORP.-48.88%9 220